Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

C&D Emerging Investment

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 11
Average round size
info
The average size of a deal this fund participated in
$81M
Portfolio companies 8
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.27
Key employees Soon

Areas of investment

  • Health Care
  • Medical
  • Pharmaceutical
  • Medical Device
  • Biotechnology

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accelerate New York Seed Fund Melville, New York, United States
Audax Group Boston, Massachusetts, United States
ClearVision Equity Partners California, San Diego, United States
Clouse SA -
Community Development Financial Institutions Fund (CDFI Fund) -
Cuneo & Co. -
Dingchu Investment China, Shanghai
Franchise India Holdings Limited Delhi, India, New Delhi
NMA Ventures Albuquerque, New Mexico, United States
Pembroke VCT England, London, United Kingdom
Profile Capital -
Sempra Energy California, San Diego, United States
Sonovate England, London, United Kingdom
The University of Chicago Innovation Fund Chicago, Illinois, United States
VGI Global Media Bangkok, Krung Thep, Thailand
Zhuhai Yuansheng Ziben Guanli China, Guangdong, Zhuhai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Oricell Therapeutics

Health Care
Pharmaceutical
Product Research
$45M28 Feb 2023 Shanghai, Shanghai, China

OriginCell

Biopharma
Biotechnology
Medical
Medical Device
$120M01 Aug 2022 Zhangdian District, Shandong, China

Berry Oncology

Health Care
Medical
Medical Device
$99M05 Aug 2021 Fuzhou, Jiangxi, China

XINGYUN GROUP

B2B
Cosmetics
E-Commerce
Logistics
Supply Chain Management
$200M24 Sep 2020 Futian District, Guangdong Province, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent C&D Emerging Investment?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 11
Average round size 81M
Peak activity year 2022
Lead investments 1
Follow on index 0.27
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Oricell Therapeutics

Health Care
Pharmaceutical
Product Research
$45M28 Feb 2023 Shanghai, Shanghai, China

OriginCell

Biopharma
Biotechnology
Medical
Medical Device
$120M01 Aug 2022 Zhangdian District, Shandong, China

Berry Oncology

Health Care
Medical
Medical Device
$99M05 Aug 2021 Fuzhou, Jiangxi, China

XINGYUN GROUP

B2B
Cosmetics
E-Commerce
Logistics
Supply Chain Management
$200M24 Sep 2020 Futian District, Guangdong Province, China
Crunchbase icon

Content report

The following text will be sent to our editors: